位置:首页 > 蛋白库 > ZSWM8_HUMAN
ZSWM8_HUMAN
ID   ZSWM8_HUMAN             Reviewed;        1837 AA.
AC   A7E2V4; B2RP37; O94987; Q17RS8; Q2TAB8; Q6P439; Q8IW81; Q8NB34; Q9H8F3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 1.
DT   03-AUG-2022, entry version 111.
DE   RecName: Full=Zinc finger SWIM domain-containing protein 8 {ECO:0000305};
GN   Name=ZSWIM8 {ECO:0000303|PubMed:24012004, ECO:0000303|PubMed:33184234,
GN   ECO:0000303|PubMed:33184237, ECO:0000312|HGNC:HGNC:23528};
GN   Synonyms=KIAA0913 {ECO:0000303|PubMed:10048485};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [2]
RP   SEQUENCE REVISION.
RA   Ohara O., Suyama M., Kikuno R., Nagase T., Ishikawa K.;
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 662-1837 (ISOFORM 2), AND NUCLEOTIDE SEQUENCE [LARGE
RP   SCALE MRNA] OF 741-1837 (ISOFORM 3).
RC   TISSUE=Brain, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-69 (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 732-1837 (ISOFORM 4).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-567 AND SER-1836, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-437 AND SER-1267, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-48; THR-1139 AND
RP   SER-1160, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   FUNCTION.
RX   PubMed=24012004; DOI=10.1016/j.neuron.2013.06.035;
RA   Wang Z., Hou Y., Guo X., van der Voet M., Boxem M., Dixon J.E.,
RA   Chisholm A.D., Jin Y.;
RT   "The EBAX-type Cullin-RING E3 ligase and Hsp90 guard the protein quality of
RT   the SAX-3/Robo receptor in developing neurons.";
RL   Neuron 79:903-916(2013).
RN   [12]
RP   FUNCTION, PATHWAY, AND IDENTIFICATION IN A SCF-LIKE E3 UBIQUITIN-PROTEIN
RP   LIGASE COMPLEX.
RX   PubMed=33184234; DOI=10.1126/science.abc9546;
RA   Han J., LaVigne C.A., Jones B.T., Zhang H., Gillett F., Mendell J.T.;
RT   "A ubiquitin ligase mediates target-directed microRNA decay independently
RT   of tailing and trimming.";
RL   Science 0:0-0(2020).
RN   [13]
RP   FUNCTION, AND PATHWAY.
RX   PubMed=33184237; DOI=10.1126/science.abc9359;
RA   Shi C.Y., Kingston E.R., Kleaveland B., Lin D.H., Stubna M.W., Bartel D.P.;
RT   "The ZSWIM8 ubiquitin ligase mediates target-directed microRNA
RT   degradation.";
RL   Science 0:0-0(2020).
CC   -!- FUNCTION: Substrate recognition component of a SCF-like E3 ubiquitin-
CC       protein ligase complex that promotes target-directed microRNA
CC       degradation (TDMD), a process that mediates degradation of microRNAs
CC       (miRNAs) (PubMed:33184234, PubMed:33184237). The SCF-like E3 ubiquitin-
CC       protein ligase complex acts by catalyzing ubiquitination and subsequent
CC       degradation of AGO proteins (AGO1, AGO2, AGO3 and/or AGO4), thereby
CC       exposing miRNAs for degradation (PubMed:33184234, PubMed:33184237).
CC       Specifically recognizes and binds AGO proteins when they are engaged
CC       with a TDMD target (PubMed:33184234). May also act as a regulator of
CC       axon guidance: specifically recognizes misfolded ROBO3 and promotes its
CC       ubiquitination and subsequent degradation (PubMed:24012004).
CC       {ECO:0000269|PubMed:24012004, ECO:0000269|PubMed:33184234,
CC       ECO:0000269|PubMed:33184237}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:33184234, ECO:0000269|PubMed:33184237}.
CC   -!- SUBUNIT: Component of the SCF-like E3 ubiquitin-protein ligase complex
CC       which contains CUL3, RBX1, ELOB, ELOC and ZSWIM8.
CC       {ECO:0000305|PubMed:33184234}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q3UHH1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=A7E2V4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A7E2V4-2; Sequence=VSP_029590, VSP_029591;
CC       Name=3;
CC         IsoId=A7E2V4-3; Sequence=VSP_029586, VSP_029587, VSP_029590;
CC       Name=4;
CC         IsoId=A7E2V4-4; Sequence=VSP_029586;
CC       Name=5;
CC         IsoId=A7E2V4-5; Sequence=VSP_029590;
CC   -!- SIMILARITY: Belongs to the ZSWIM8 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI37250.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=AAI37251.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAA74936.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA74936.2; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=BAB14664.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC03709.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB020720; BAA74936.2; ALT_SEQ; mRNA.
DR   EMBL; AC022400; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC040726; AAH40726.1; -; mRNA.
DR   EMBL; BC063694; AAH63694.1; -; mRNA.
DR   EMBL; BC111006; AAI11007.1; -; mRNA.
DR   EMBL; BC117205; AAI17206.1; -; mRNA.
DR   EMBL; BC137249; AAI37250.1; ALT_SEQ; mRNA.
DR   EMBL; BC137250; AAI37251.1; ALT_SEQ; mRNA.
DR   EMBL; BC151206; AAI51207.1; -; mRNA.
DR   EMBL; AK023742; BAB14664.1; ALT_INIT; mRNA.
DR   EMBL; AK091621; BAC03709.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS44440.1; -. [A7E2V4-4]
DR   CCDS; CCDS60560.1; -. [A7E2V4-1]
DR   RefSeq; NP_001229416.1; NM_001242487.1. [A7E2V4-1]
DR   RefSeq; NP_001229417.1; NM_001242488.1. [A7E2V4-2]
DR   RefSeq; NP_055852.2; NM_015037.3. [A7E2V4-4]
DR   RefSeq; XP_006717788.1; XM_006717725.3. [A7E2V4-5]
DR   AlphaFoldDB; A7E2V4; -.
DR   BioGRID; 116690; 54.
DR   IntAct; A7E2V4; 29.
DR   MINT; A7E2V4; -.
DR   STRING; 9606.ENSP00000381693; -.
DR   iPTMnet; A7E2V4; -.
DR   PhosphoSitePlus; A7E2V4; -.
DR   BioMuta; ZSWIM8; -.
DR   EPD; A7E2V4; -.
DR   jPOST; A7E2V4; -.
DR   MassIVE; A7E2V4; -.
DR   MaxQB; A7E2V4; -.
DR   PaxDb; A7E2V4; -.
DR   PeptideAtlas; A7E2V4; -.
DR   PRIDE; A7E2V4; -.
DR   ProteomicsDB; 1797; -. [A7E2V4-1]
DR   ProteomicsDB; 1798; -. [A7E2V4-2]
DR   ProteomicsDB; 1799; -. [A7E2V4-3]
DR   ProteomicsDB; 1800; -. [A7E2V4-4]
DR   ProteomicsDB; 1801; -. [A7E2V4-5]
DR   Antibodypedia; 48437; 5 antibodies from 5 providers.
DR   DNASU; 23053; -.
DR   Ensembl; ENST00000398706.6; ENSP00000381693.2; ENSG00000214655.11. [A7E2V4-4]
DR   Ensembl; ENST00000605216.5; ENSP00000474748.1; ENSG00000214655.11. [A7E2V4-1]
DR   GeneID; 23053; -.
DR   KEGG; hsa:23053; -.
DR   UCSC; uc001jve.4; human. [A7E2V4-1]
DR   CTD; 23053; -.
DR   GeneCards; ZSWIM8; -.
DR   HGNC; HGNC:23528; ZSWIM8.
DR   HPA; ENSG00000214655; Low tissue specificity.
DR   MIM; 619213; gene.
DR   neXtProt; NX_A7E2V4; -.
DR   OpenTargets; ENSG00000214655; -.
DR   PharmGKB; PA134885317; -.
DR   VEuPathDB; HostDB:ENSG00000214655; -.
DR   eggNOG; KOG3615; Eukaryota.
DR   GeneTree; ENSGT00940000156999; -.
DR   InParanoid; A7E2V4; -.
DR   OrthoDB; 88229at2759; -.
DR   PhylomeDB; A7E2V4; -.
DR   TreeFam; TF324881; -.
DR   PathwayCommons; A7E2V4; -.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   SignaLink; A7E2V4; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 23053; 87 hits in 1082 CRISPR screens.
DR   ChiTaRS; ZSWIM8; human.
DR   GenomeRNAi; 23053; -.
DR   Pharos; A7E2V4; Tdark.
DR   PRO; PR:A7E2V4; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; A7E2V4; protein.
DR   Bgee; ENSG00000214655; Expressed in lower esophagus mucosa and 191 other tissues.
DR   ExpressionAtlas; A7E2V4; baseline and differential.
DR   Genevisible; A7E2V4; HS.
DR   GO; GO:0031462; C:Cul2-RING ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0031463; C:Cul3-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:1990756; F:ubiquitin ligase-substrate adaptor activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:2000627; P:positive regulation of miRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   InterPro; IPR007527; Znf_SWIM.
DR   PROSITE; PS50966; ZF_SWIM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Metal-binding; Phosphoprotein;
KW   Reference proteome; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..1837
FT                   /note="Zinc finger SWIM domain-containing protein 8"
FT                   /id="PRO_0000311802"
FT   ZN_FING         172..208
FT                   /note="SWIM-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00325"
FT   REGION          45..65
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          514..727
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          803..823
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1016..1232
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1442..1464
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1635..1656
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        522..550
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1018..1044
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1144..1160
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1174..1202
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         48
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         53
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHH1"
FT   MOD_RES         437
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         567
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         1139
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHH1"
FT   MOD_RES         1156
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHH1"
FT   MOD_RES         1160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1836
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   VAR_SEQ         936
FT                   /note="P -> PVVSPT (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029586"
FT   VAR_SEQ         1006
FT                   /note="K -> KVTASVFQ (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029587"
FT   VAR_SEQ         1604..1612
FT                   /note="CELWGQGTV -> L (in isoform 2, isoform 3 and isoform
FT                   5)"
FT                   /evidence="ECO:0000303|PubMed:10048485,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029590"
FT   VAR_SEQ         1712..1837
FT                   /note="VNYVHQFCVGAAKGVLSPFVLQEIVMETLQRLSPAHAHNHLRAPAFHQLVQR
FT                   CQQAYMQYIHHRLIHLTPADYDDFVNAIRSARSAFCLTPMGMMQFNDILQNLKRSKQTK
FT                   ELWQRVSLEMATFSP -> DRHGDAAAAESRSCPQPPACPGLPPTGAALPAGIHAVHPP
FT                   PLDSPDSCGLRRLCECDPECPQRLLPDAHGHDAVQRHPTEPQAQQTDQGAVAAGLTRDG
FT                   HLLPLSLSPLGSYTGTQACGYGGPSHRGSETWLDRSSSLSSLVAQTDSCSWAIAWGQDV
FT                   SHPRSLGLGETALSGRGRWVASGIYLAFINI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029591"
FT   CONFLICT        751
FT                   /note="A -> D (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        762
FT                   /note="K -> M (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        774
FT                   /note="F -> S (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1052
FT                   /note="A -> T (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1136
FT                   /note="K -> M (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1165
FT                   /note="R -> Q (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1184
FT                   /note="S -> N (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1252
FT                   /note="A -> T (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1401
FT                   /note="E -> V (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1775
FT                   /note="R -> S (in Ref. 5; BAB14664)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1837 AA;  197297 MW;  391CF6AE25E4F8C6 CRC64;
     MELMFAEWED GERFSFEDSD RFEEDSLCSF ISEAESLCQN WRGWRKQSAG PNSPTGGGGG
     GGSGGTRMRD GLVIPLVELS AKQVAFHIPF EVVEKVYPPV PEQLQLRIAF WSFPENEEDI
     RLYSCLANGS ADEFQRGDQL FRMRAVKDPL QIGFHLSATV VPPQMVPPKG AYNVAVMFDR
     CRVTSCSCTC GAGAKWCTHV VALCLFRIHN ASAVCLRAPV SESLSRLQRD QLQKFAQYLI
     SELPQQILPT AQRLLDELLS SQSTAINTVC GAPDPTAGPS ASDQSTWYLD ESTLTDNIKK
     TLHKFCGPSP VVFSDVNSMY LSSTEPPAAA EWACLLRPLR GREPEGVWNL LSIVREMFKR
     RDSNAAPLLE ILTDQCLTYE QITGWWYSVR TSASHSSASG HTGRSNGQSE VAAHACASMC
     DEMVTLWRLA VLDPALSPQR RRELCTQLRQ WQLKVIENVK RGQHKKTLER LFPGFRPAVE
     ACYFNWEEAY PLPGVTYSGT DRKLALCWAR ALPSRPGASR SGGLEESRDR PRPLPTEPAV
     RPKEPGTKRK GLGEGVPSSQ RGPRRLSAEG GDKALHKMGP GGGKAKALGG AGSGSKGSAG
     GGSKRRLSSE DSSLEPDLAE MSLDDSSLAL GAEASTFGGF PESPPPCPLH GGSRGPSTFL
     PEPPDTYEED GGVYFSEGPE PPTASVGPPG LLPGDVCTQD DLPSTDESGN GLPKTKEAAP
     AVGEEDDDYQ AYYLNAQDGA GGEEEKAEGG AGEEHDLFAG LKPLEQESRM EVLFACAEAL
     HAHGYSSEAS RLTVELAQDL LANPPDLKVE PPPAKGKKNK VSTSRQTWVA TNTLSKAAFL
     LTVLSERPEH HNLAFRVGMF ALELQRPPAS TKALEVKLAY QESEVAALLK KIPLGPSEMS
     TMRCRAEELR EGTLCDYRPV LPLMLASFIF DVLCAPGSRP PSRNWNSETP GDEELGFEAA
     VAALGMKTTV SEAEHPLLCE GTRREKGDLA LALMITYKDD QAKLKKILDK LLDRESQTHK
     PQTLSSFYSS SRPTTASQRS PSKHGGPSAP GALQPLTSGS AGPAQPGSVA GAGPGPTEGF
     TEKNVPESSP HSPCEGLPSE AALTPRPEGK VPSRLALGSR GGYNGRGWGS PGRPKKKHTG
     MASIDSSAPE TTSDSSPTLS RRPLRGGWAP TSWGRGQDSD SISSSSSDSL GSSSSSGSRR
     ASASGGARAK TVEVGRYKGR RPESHAPHVP NQPSEAAAHF YFELAKTVLI KAGGNSSTSI
     FTHPSSSGGH QGPHRNLHLC AFEIGLYALG LHNFVSPNWL SRTYSSHVSW ITGQAMEIGS
     AALTILVECW DGHLTPPEVA SLADRASRAR DSNMVRAAAE LALSCLPHAH ALNPNEIQRA
     LVQCKEQDNL MLEKACMAVE EAAKGGGVYP EVLFEVAHQW FWLYEQTAGG SSTAREGATS
     CSASGIRAGG EAGRGMPEGR GGPGTEPVTV AAAAVTAAAT VVPVISVGSS LYPGPGLGHG
     HSPGLHPYTA LQPHLPCSPQ YLTHPAHPAH PMPHMPRPAV FPVPSSAYPQ GVHPAFLGAQ
     YPYSVTPPSL AATAVSFPVP SMAPITVHPY HTEPGLPLPT SVACELWGQG TVSSVHPAST
     FPAIQGASLP ALTTQPSPLV SGGFPPPEEE THSQPVNPHS LHHLHAAYRV GMLALEMLGR
     RAHNDHPNNF SRSPPYTDDV KWLLGLAAKL GVNYVHQFCV GAAKGVLSPF VLQEIVMETL
     QRLSPAHAHN HLRAPAFHQL VQRCQQAYMQ YIHHRLIHLT PADYDDFVNA IRSARSAFCL
     TPMGMMQFND ILQNLKRSKQ TKELWQRVSL EMATFSP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024